NCT00969839
Unknown
Phase 4
A Study to Evaluate the Safety and Effectiveness of the NovaLign Intramedullary Fixation System for the Treatment of Humeral Diaphysis Fractures
NovaLign Orthopaedics, Inc2 sites in 1 country20 target enrollmentSeptember 2009
ConditionsFracture
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Fracture
- Sponsor
- NovaLign Orthopaedics, Inc
- Enrollment
- 20
- Locations
- 2
- Primary Endpoint
- Radiographic union and safety
- Last Updated
- 16 years ago
Overview
Brief Summary
This post-market clinical study is being done to evaluate the use of the NovaLign™ Intramedullary Fixation System in the treatment of humeral fractures.
Detailed Description
This is an observational, prospective, nonrandomized open label, post-market clinical study, designed to evaluate the use a flexible intramedullary fixation device used in the treatment of fractures of the humerus. This is a multicentre trial.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Humeral Fracture
- •Surgical intervention can be performed within 14 days of injury (injury being Day 0 for this particular criteria)
- •Fully functioning contralateral limb (e.g., hand, arm, shoulder)
- •Age 18 years or older and skeletally mature
Exclusion Criteria
- •Intraarticular fractures or those involving shoulder or elbow of the index arm
- •Pathologic fracture (e.g., tumor involvement, osteomalacia, etc.; osteoporosis is not an exclusion)
- •Evidence of neurologic injury in the index arm, including compartment syndrome or radial nerve palsy
- •Additional upper body injuries (e.g., upper extremity, abdominal, thoracic, neck or head injury) that may affect or inhibit the evaluation of the index or contralateral arm, shoulder, elbow, etc or would not allow the patient to follow or comply with appropriate post-operative regimens
- •Any previous bodily injury or surgery that may interfere with function or evaluation of index or contralateral arm, shoulder, elbow, etc.
Outcomes
Primary Outcomes
Radiographic union and safety
Time Frame: 12 months
Secondary Outcomes
- Function, pain, and quality of life assessments at regular intervals(12 months)
Study Sites (2)
Loading locations...
Similar Trials
Completed
Not Applicable
Effectiveness Of The Fibulock Intramedullary NailFibula FractureNCT02688296Arthrex, Inc.34
Terminated
Not Applicable
IntErnational Long-term Follow-up Study of Patients With Uncontrolled HyperTensioNHypertensionBlood PressureNCT01705080Abbott Medical Devices276
Completed
Not Applicable
Safety & Effectiveness of Wortie Freeze Plus in Common and Plantar WartsCommon WartPlantar WartNCT05115669Karo Pharma AB50
Active, not recruiting
Not Applicable
Clinical Study Of a Micro-Implantable Pulse Generator For The Treatment of Peripheral Neuropathic PainPeripheral NeuralgiaChronic PainNCT05287373Nalu Medical, Inc.89
Active, not recruiting
Not Applicable
Clinical Study of a Micro-Implantable Pulse Generator for the Treatment of Peripheral Neuropathic Pain (COMFORT 2)Peripheral NeuralgiaPeripheral NeuropathyChronic PainNCT05870124Nalu Medical, Inc.185